These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 31000491

  • 21. Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen.
    Osei Sekyere J.
    Microbiologyopen; 2018 Aug; 7(4):e00578. PubMed ID: 29345117
    [Abstract] [Full Text] [Related]

  • 22. Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
    Iguchi S, Itakura Y, Yoshida A, Kamada K, Mizushima R, Arai Y, Uzawa Y, Kikuchi K.
    J Infect Chemother; 2019 Oct; 25(10):743-749. PubMed ID: 31257156
    [Abstract] [Full Text] [Related]

  • 23. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia.
    Calvo B, Melo AS, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, Meis JF, Colombo AL.
    J Infect; 2016 Oct; 73(4):369-74. PubMed ID: 27452195
    [Abstract] [Full Text] [Related]

  • 24. Attack, Defend and Persist: How the Fungal Pathogen Candida auris was Able to Emerge Globally in Healthcare Environments.
    de Jong AW, Hagen F.
    Mycopathologia; 2019 Jun; 184(3):353-365. PubMed ID: 31209693
    [Abstract] [Full Text] [Related]

  • 25. Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins.
    Borman AM, Szekely A, Johnson EM.
    Med Mycol; 2017 Jul 01; 55(5):563-567. PubMed ID: 28204557
    [Abstract] [Full Text] [Related]

  • 26. Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017.
    Belkin A, Gazit Z, Keller N, Ben-Ami R, Wieder-Finesod A, Novikov A, Rahav G, Brosh-Nissimov T.
    Emerg Infect Dis; 2018 Apr 01; 24(4):801-804. PubMed ID: 29553329
    [Abstract] [Full Text] [Related]

  • 27. Methods for identification of Candida auris, the yeast of global public health concern: A review.
    Mahmoudi S, Agha Kuchak Afshari S, Aghaei Gharehbolagh S, Mirhendi H, Makimura K.
    J Mycol Med; 2019 Jun 01; 29(2):174-179. PubMed ID: 31031132
    [Abstract] [Full Text] [Related]

  • 28. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW.
    Clin Infect Dis; 2009 Mar 15; 48(6):e57-61. PubMed ID: 19193113
    [Abstract] [Full Text] [Related]

  • 29. Candida auris: An emerging multidrug-resistant pathogen.
    Sears D, Schwartz BS.
    Int J Infect Dis; 2017 Oct 15; 63():95-98. PubMed ID: 28888662
    [Abstract] [Full Text] [Related]

  • 30. Multidrug-resistant Candida auris: an epidemiological review.
    Chakrabarti A, Singh S.
    Expert Rev Anti Infect Ther; 2020 Jun 15; 18(6):551-562. PubMed ID: 32237924
    [Abstract] [Full Text] [Related]

  • 31. Persistent candidemia despite appropriate fungal therapy: First case of Candida auris from the United Arab Emirates.
    Alatoom A, Sartawi M, Lawlor K, AbdelWareth L, Thomsen J, Nusair A, Mirza I.
    Int J Infect Dis; 2018 May 15; 70():36-37. PubMed ID: 29452247
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
    Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R.
    Emerg Infect Dis; 2017 Feb 15; 23(2):328-331. PubMed ID: 28098553
    [Abstract] [Full Text] [Related]

  • 34. Nosocomial fungemia by Candida auris: First four reported cases in continental Europe.
    Ruiz Gaitán AC, Moret A, López Hontangas JL, Molina JM, Aleixandre López AI, Cabezas AH, Mollar Maseres J, Arcas RC, Gómez Ruiz MD, Chiveli MÁ, Cantón E, Pemán J.
    Rev Iberoam Micol; 2017 Feb 15; 34(1):23-27. PubMed ID: 28131716
    [Abstract] [Full Text] [Related]

  • 35. First case of Candida auris infection in Belgium in a surgical patient from Kuwait.
    Dewaele K, Frans J, Smismans A, Ho E, Tollens T, Lagrou K.
    Acta Clin Belg; 2020 Jun 15; 75(3):221-228. PubMed ID: 30514182
    [Abstract] [Full Text] [Related]

  • 36. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
    Wurster S, Bandi A, Beyda ND, Albert ND, Raman NM, Raad II, Kontoyiannis DP.
    J Antimicrob Chemother; 2019 Jul 01; 74(7):1904-1910. PubMed ID: 31225606
    [Abstract] [Full Text] [Related]

  • 37. Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan?
    Lu PL, Liu WL, Lo HJ, Wang FD, Ko WC, Hsueh PR, Ho MW, Liu CE, Chen YH, Chen YC, Chuang YC, Chang SC.
    J Formos Med Assoc; 2018 Jun 01; 117(6):462-470. PubMed ID: 29122404
    [Abstract] [Full Text] [Related]

  • 38. Candida auris, what do paediatricians need to know?
    Warris A.
    Arch Dis Child; 2018 Sep 01; 103(9):891-894. PubMed ID: 29545411
    [Abstract] [Full Text] [Related]

  • 39. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF.
    J Antimicrob Chemother; 2018 Apr 01; 73(4):891-899. PubMed ID: 29325167
    [Abstract] [Full Text] [Related]

  • 40. Risk factors, antifungal susceptibility, complications, and outcome of Candida auris bloodstream infection in a tertiary care center in the western region of Saudi Arabia.
    Munshi A, Almadani F, Ossenkopp J, Alharbi M, Althaqafi A, Alsaedi A, Al-Amri A, Almarhabi H.
    J Infect Public Health; 2024 Jan 01; 17(1):182-188. PubMed ID: 38039862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.